Objective: To investigate the incidence of allergic and respiratory diseases through age 3 years in children fed docosahexaenoic acid (DHA)- and arachidonic acid (ARA)-supplemented formula during infancy.
Study Design: Children who completed randomized, double-blind studies of DHA/ARA-supplemented (0.32%-0.